Date: Tuesday 28th September

Time: 12:30pm

Register Now


Driven by ageing populations, increasing obesity and decreasing physical activity, the prevalence of diabetes is expected to rise by 55% to 592 million individuals worldwide by 2035. Traditionally a disease of middle and older age, type 2 diabetes is increasingly diagnosed in younger patients . To compare the glycaemic control and cardiovascular risk factor profiles of younger and older patients with type 2 diabetes. Cross-sectional analysis of data from the Australian National Diabetes Audit (ANDA) was undertaken.

This presentation will look out the outcomes of this study and discuss the treatment options available to support improved long term outcomes.

This webinar is suitable for GPs, diabetes educators and other interested clinicians.

About the Presenter

Dr Natalie Nanayakkara’s clinical practice includes general endocrinology and diabetes with a special interest in type 2 diabetes. Natalie actively participates in endocrine research: participating in clinical trials, assisting in the formulation of national guidelines and educational programs, and publications in peer reviewed diabetes and endocrine journals.

More Information

You can view the full specialist bios of the presenters as well as our other specialists on the FDT Website:

If you are a GP working in a rural or remote area and would like to access the FDT service to offer specialists appointments to your patients, you can view our service information and complete an expression of interest